Serum metabolome analysis by 1H-NMR reveals differences between chronic lymphocytic leukaemia molecular subgroups (original) (raw)

• Garand R, Robillard N . Immunophenotypic characterization of acute leukemias and chronic lymphoproliferative disorders: practical recommendations and classifications. Hematol Cell Ther 1996; 38: 471–486.
  Article CAS PubMed Google Scholar
• Hamblin T . Chronic lymphocytic leukaemia: one disease or two? Ann Hematol 2002; 81: 299–303.
  Article CAS PubMed Google Scholar
• Dighiero G . Unsolved issues in CLL biology and management. Leukemia 2003; 17: 2385–2391.
  Article CAS PubMed Google Scholar
• Rai KR, Sawitsky A, Cronkite EP, Chanana AD, Levy RN, Pasternack BS . Clinical staging of chronic lymphocytic leukemia. Blood 1975; 46: 219–234.
  CAS PubMed Google Scholar
• Binet JL, Lepoprier M, Dighiero G, Charron D, D’Athis P, Vaugier G et al. A clinical staging system for chronic lymphocytic leukemia: prognostic significance. Cancer 1977; 40: 855–864.
  Article CAS PubMed Google Scholar
• Dighiero G, Maloum K, Desablens B, Cazin B, Navarro M, Leblay R et al. Chlorambucil in indolent chronic lymphocytic leukemia. French cooperative group on chronic lymphocytic leukemia. N Engl J Med 1998; 338: 1506–1514.
  Article CAS PubMed Google Scholar
• Krober A, Seiler T, Benner A, Bullinger L, Bruckle E, Lichter P et al. V(H) mutation status, CD38 expression level, genomic aberrations, and survival in chronic lymphocytic leukemia. Blood 2002; 100: 1410–1416.
  CAS PubMed Google Scholar
• Oscier DG, Gardiner AC, Mould SJ, Glide S, Davis ZA, Ibbotson RE et al. Multivariate analysis of prognostic factors in CLL: clinical stage, IGVH gene mutational status, and loss or mutation of the p53 gene are independent prognostic factors. Blood 2002; 100: 1177–1184.
  CAS PubMed Google Scholar
• Damle RN, Wasil T, Fais F, Ghiotto F, Valetto A, Allen SL et al. Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood 1999; 94: 1840–1847.
  CAS PubMed Google Scholar
• Hamblin TJ, Davis Z, Gardiner A, Oscier DG, Stevenson FK . Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood 1999; 94: 1848–1854.
  CAS PubMed Google Scholar
• Rosenwald A, Alizadeh AA, Widhopf G, Simon R, Davis RE, Yu X et al. Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia. J Exp Med 2001; 194: 1639–1647.
  Article CAS PubMed PubMed Central Google Scholar
• Crespo M, Bosch F, Villamor N, Bellosillo B, Colomer D, Rozman M et al. ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia. N Engl J Med 2003; 348: 1764–1775.
  Article CAS PubMed Google Scholar
• Orchard JA, Ibbotson RE, Davis Z, Wiestner A, Rosenwald A, Thomas PW et al. ZAP-70 expression and prognosis in chronic lymphocytic leukaemia. Lancet 2004; 363: 105–111.
  Article CAS PubMed Google Scholar
• Rassenti LZ, Huynh L, Toy TL, Chen L, Keating MJ, Gribben JG et al. ZAP-70 compared with immunoglobulin heavy-chain gene mutation status as a predictor of disease progression in chronic lymphocytic leukemia. N Engl J Med 2004; 351: 893–901.
  Article CAS PubMed Google Scholar
• Reinoso-Martin C, Jantus-Lewintre E, Ballesteros CG, Campos CB, Ferrer JR, Garcia-Conde J . ZAP-70 mRNA expression provides clinically valuable information in early-stage chronic lymphocytic leukemia. Haematologica 2008; 93: 1422–1424.
  Article PubMed Google Scholar
• Wiestner A, Rosenwald A, Barry TS, Wright G, Davis RE, Henrickson SE et al. ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profile. Blood 2003; 101: 4944–4951.
  Article CAS PubMed Google Scholar
• Jantus-Lewintre E, Reinoso-Martin C, Montaner D, Marín M, Terol MJ, Farrás R et al. Analysis of CLL transcriptomic profile: differences between molecular subgroups. Leuk Lymph 2009; 50: 68–79.
  Article Google Scholar
• Stratowa C, Loffler G, Lichter P, Stilgenbauer S, Haberl P, Schweifer N et al. CDNA microarray gene expression analysis of B-cell chronic lymphocytic leukemia proposes potential new prognostic markers involved in lymphocyte trafficking. Int J Cancer 2001; 91: 474–480.
  Article CAS PubMed Google Scholar
• Gygi SP, Rochon Y, Franza BR, Aebersold R . Correlation between protein and mRNA abundance in yeast. Mol Cell Biol 1999; 19: 1720–1730.
  Article CAS PubMed PubMed Central Google Scholar
• D’Arena G, Musto P, Cascavilla N, Dell’Olio M, Di Renzo N, Perla G et al. CD38 expression correlates with adverse biological features and predicts poor clinical outcome in B-cell chronic lymphocytic leukemia. Leuk Lymphoma 2001; 42: 109–114.
  Article PubMed Google Scholar
• Del Poeta G, Maurillo L, Venditti A, Buccisano F, Epiceno AM, Capelli G et al. Clinical significance of CD38 expression in chronic lymphocytic leukemia. Blood 2001; 98: 2633–2639.
  Article CAS PubMed Google Scholar
• Ibrahim S, Keating M, Do KA, O’Brien S, Huh YO, Jilani I et al. CD38 expression as an important prognostic factor in B-cell chronic lymphocytic leukemia. Blood 2001; 98: 181–186.
  Article CAS PubMed Google Scholar
• Nicholson JK, Lindon JC . Systems biology: metabonomics. Nature 2008; 455: 1054–1056.
  Article CAS PubMed Google Scholar
• Nicholson JK, Wilson ID . Opinion: understanding ‘global’ systems biology: metabonomics and the continuum of metabolism. Nat Rev Drug Discov 2003; 2: 668–676.
  Article CAS PubMed Google Scholar
• Kaddurah-Daouk R, Kristal BS, Weinshilboum RM . Metabolomics: a global biochemical approach to drug response and disease. Annu Rev Pharmacol Toxicol 2008; 48: 653–683.
  Article CAS PubMed Google Scholar
• Keun HC, Athersuch TJ . Application of metabonomics in drug development. Pharmacogenomics 2007; 8: 731–741.
  Article CAS PubMed Google Scholar
• Lewis GD, Asnani A, Gerszten RE . Application of metabolomics to cardiovascular biomarker and pathway discovery. J Am Coll Cardiol 2008; 52: 117–123.
  Article CAS PubMed PubMed Central Google Scholar
• Brindle JT, Antti H, Holmes E, Tranter G, Nicholson JK, Bethell HW et al. Rapid and noninvasive diagnosis of the presence and severity of coronary heart disease using 1H-NMR-based metabonomics. Nat Med 2002; 8: 1439–1444.
  Article CAS PubMed Google Scholar
• Makinen VP, Soininen P, Forsblom C, Parkkonen M, Ingman P, Kaski K et al. 1H NMR metabonomics approach to the disease continuum of diabetic complications and premature death. Mol Syst Biol 2008; 4: 167.
  Article PubMed PubMed Central Google Scholar
• Zhou J, Xu B, Huang J, Jia X, Xue J, Shi X et al. 1H NMR-based metabonomic and pattern recognition analysis for detection of oral squamous cell carcinoma. Clin Chim Acta 2009; 401: 8–13.
  Article CAS PubMed Google Scholar
• Odunsi K, Wollman RM, Ambrosone CB, Hutson A, McCann SE, Tammela J et al. Detection of epithelial ovarian cancer using 1H-NMR-based metabonomics. Int J Cancer 2005; 113: 782–788.
  Article CAS PubMed Google Scholar
• Tiziani S, Lopes V, Gunther UL . Early stage diagnosis of oral cancer using 1H NMR-based metabolomics. Neoplasia 2009; 11: 269–276, .
  Article CAS PubMed PubMed Central Google Scholar
• Sreekumar A, Poisson LM, Rajendiran TM, Khan AP, Cao Q, Yu J et al. Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression. Nature 2009; 457: 910–914.
  Article CAS PubMed PubMed Central Google Scholar
• Nicholson JK, Wilson ID . High resolution proton magnetic resonance spectroscopy of biological fluids. Prog Nucl Magn Reson Spectrosc 1989; 21: 449–501.
  Article CAS Google Scholar
• Ernst RR, Bodenhausen G, Wokaun A . Principles of Nuclear Magnetic Resonance in One and Two Dimensions 1987, Oxford University Press: New York.
  Google Scholar
• Jantus-Lewintre E, Reinoso-Martin C, Ballesteros CG, Montaner D, Farrás-Rivera R, Ramós-Mayans J et al. Crytochome-1 expression: a new prognostic marker in B-cell chronic lymphocytic leukemia. Haematologica 2009; 94: 280–284.
  Article Google Scholar
• Matthews C, Catherwood M, Morris TC, Alexander HD . Routine analysis of IgVH mutational status in CLL patients using BIOMED-2 standardized primers and protocols. Leuk Lymphoma 2004; 45: 1899–1904.
  Article PubMed Google Scholar
• van Dongen JJ, Langerak AW, Bruggemann M, Evans PA, Hummel M, Lavender FL et al. Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia 2003; 17: 2257–2317.
  Article CAS PubMed Google Scholar
• Ghia P, Stamatopoulos K, Belessi C, Moreno C, Stilgenbauer S, Stevenson F et al. ERIC recommendations on IGHV gene mutational status analysis in chronic lymphocytic leukemia. Leukemia 2007; 21: 1–3.
  Article CAS PubMed Google Scholar
• Beckonert O, Keun HC, Ebbels TM, Bundy J, Holmes E, Lindon JC et al. Metabolic profiling, metabolomic and metabonomic procedures for NMR spectroscopy of urine, plasma, serum and tissue extracts. Nat Protoc 2007; 2: 2692–2703.
  Article CAS PubMed Google Scholar
• Meiboom S, Gill D . Modified spin-echo method for measuring nuclear relaxation time. Rev Sci Instrum 1958; 20: 688–691.
  Article Google Scholar
• Ala-Korpela M . 1H-NMR spectroscopy of human blood plasma. Prog Nucl Magn Reson Spectrosc 1995; 27: 475–554.
  Article CAS Google Scholar
• Nicholson JK, Foxall PJ, Spraul M, Farrant RD, Lindon JC . 750 MHz 1H and 1H-13C NMR spectroscopy of human blood plasma. Anal Chem 1995; 67: 793–811.
  Article CAS PubMed Google Scholar
• Anthony ML, Sweatman BC, Beddell CR, Lindon JC, Nicholson JK . Pattern recognition classification of the site of nephrotoxicity based on metabolic data derived from proton nuclear magnetic resonance spectra of urine. Mol Pharmacol 1994; 46: 199–211.
  CAS PubMed Google Scholar
• Barton RH, Nicholson JK, Elliott P, Holmes E . High-throughput 1H NMR-based metabolic analysis of human serum and urine for large-scale epidemiological studies: validation study. Int J Epidemiol 2008; 37 (Suppl 1): i31–i40.
  Article PubMed Google Scholar
• Eriksson L, Johansson E, Kettaneh-Wold N, Trygg J, Wikström C, Wold S . Multi- and Megavariate Data Analysis Part I: Basic Principles and Applications, 2nd edn. Umetrics Academy: Umea, Sweden, 2005, pp 425 .
  Google Scholar
• Wold S . Cross-validatory estimation of number of components in factor and principal components models. Technometrics 1978; 20: 397–405.
  Article Google Scholar
• Barantin L, Le Pape A, Akoka S . A new method for absolute quantitation of MRS metabolites. Magn Reson Med 1997; 38: 179–182.
  Article CAS PubMed Google Scholar
• Dreier L, Wider G . Concentration measurements by PULCON using X-filtered or 2D NMR spectra. Magn Reson Chem 2006; 44 : S206–S212.
  Article CAS PubMed Google Scholar
• Kriat M, Confort-Gouny S, Vion-Dury J, Sciaky M, Viout P, Cozzone PJ . Quantitation of metabolites in human blood serum by proton magnetic resonance spectroscopy. A comparative study of the use of formate and TSP as concentration standards. NMR Biomed 1992; 5: 179–184.
  Article CAS PubMed Google Scholar
• Catovsky D, Fooks J, Richards S . Prognostic factors in chronic lymphocytic leukaemia: the importance of age, sex and response to treatment in survival. A report from the MRC CLL 1 trial. MRC working party on leukaemia in adults. Br J Haematol 1989; 72: 141–149.
  Article CAS PubMed Google Scholar
• Kempner W . The nature of leukemic blood cells as determined by their metabolism. J Clin Invest 1939; 18: 291–300.
  Article CAS PubMed PubMed Central Google Scholar
• Maneche HC . Blood pyruvate in malignant neoplastic disorders. Clin Chem 1966; 12: 158–164.
  CAS PubMed Google Scholar
• Mazurek S, Boschek CB, Eigenbrodt E . The role of phosphometabolites in cell proliferation, energy metabolism, and tumor therapy. J Bioenerg Biomembr 1997; 29: 315–330.
  Article CAS PubMed Google Scholar
• Mazurek S, Grimm H, Oehmke M, Weisse G, Teigelkamp S, Eigenbrodt E . Tumor M2-PK and glutaminolytic enzymes in the metabolic shift of tumor cells. Anticancer Res 2000; 20 (Suppl 6D): 5151–5154.
  CAS PubMed Google Scholar
• Oremek GM, Teigelkamp S, Kramer W, Eigenbrodt E, Usadel KH . The pyruvate kinase isoenzyme tumor M2 (Tu M2-PK) as a tumor marker for renal carcinoma. Anticancer Res 1999; 19 (Suppl 4A): 2599–2601.
  CAS PubMed Google Scholar
• Oremek GM, Rox S, Mitrou P, Sapoutzis N, Sauer-Eppel H . Tumor M2-PK levels in haematological malignancies. Anticancer Res 2003; 23 (Suppl 2A): 1135–1138.
  CAS PubMed Google Scholar
• Mazurek S, Grimm H, Boschek CB, Vaupel P, Eigenbrodt E . Pyruvate kinase type M2: a crossroad in the tumor metabolome. Br J Nutr 2002; 87 (Suppl 1): S23–S29.
  Article CAS PubMed Google Scholar
• Eck HP, Drings P, Droge W . Plasma glutamate levels, lymphocyte reactivity and death rate in patients with bronchial carcinoma. J Cancer Res Clin Oncol 1989; 115: 571–574.
  Article CAS PubMed Google Scholar
• Grimm H, Tibell A, Norrlind B, Schott J, Bohle RM . Nutrition and allorejection impact of lipids. Transpl Immunol 1995; 3: 62–67.
  Article CAS PubMed Google Scholar
• Jiang WG, Bryce RP, Horrobin DF . Essential fatty acids: molecular and cellular basis of their anti-cancer action and clinical implications. Crit Rev Oncol Hematol 1998; 27: 179–209.
  Article CAS PubMed Google Scholar
• Seligmann H, Levi R, Konijn AM, Prokocimer M . Thiamine deficiency in patients with B-chronic lymphocytic leukaemia: a pilot study. Postgrad Med J 2001; 77: 582–585.
  Article CAS PubMed PubMed Central Google Scholar
• Daefler S, Krueger GR, Modder B, Deliconstantinos G . Cell membrane fluidity in chronic lymphocytic leukemia (CLL) lymphocytes and its relation to membrane receptor expression. J Exp Pathol 1987; 3: 147–154.
  CAS PubMed Google Scholar
• Deliconstantinos G, Daefler S, Krueger GR . Cholesterol modulation of membrane fluidity and ecto-nucleotide triphosphatase activity in human normal and CLL lymphocytes. Anticancer Res 1987; 7 (3 Part B): 347–352.
  CAS PubMed Google Scholar
• Inbar M, Shinitzky M . Cholesterol as a bioregulator in the development and inhibition of leukemia. Proc Natl Acad Sci USA 1974; 71: 4229–4231.
  Article CAS PubMed PubMed Central Google Scholar
• Chen HW, Heiniger HJ . Stimulation of sterol synthesis in peripheral leukocytes of leukemic mice. Cancer Res 1974; 34: 1304–1307.
  CAS PubMed Google Scholar
• Heiniger HJ, Chen HW, Applegate OL, Schacter LP, Schacter BZ, Anderson PN . Elevated synthesis of cholesterol in human leakemic cells. J Mol Med 1976; 2: 109–116.
  Google Scholar
• Weinberg JB, Volkheimer AD, Mihovilovic M, Jiang N, Chen Y, Bond K et al. Apolipoprotein E genotype as a determinant of survival in chronic lymphocytic leukemia. Leukemia 2008; 22: 2184–2192.
  Article CAS PubMed Google Scholar
• Van Bockstaele F, Pede V, Janssens A, Callewaert F, Offner F, Verhasselt B et al. Lipoprotein lipase mRNA expression in whole blood is a prognostic marker in B cell chronic lymphocytic leukemia. Clin Chem 2007; 53: 204–212.
  Article CAS PubMed Google Scholar